Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Saudi J Biol Sci
Päätekijät: Mickymaray, Suresh, Alfaiz, Faiz Abdulaziz, Paramasivam, Anand, Veeraraghavan, Vishnu Priya, Periadurai, Nanthini Devi, Surapaneni, Krishna Mohan, Niu, Guangfeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/
https://ncbi.nlm.nih.gov/pubmed/34220214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia